E-LIB Suche - Ergebnisse für: Ruigrok, Eline

1

Preclinical Assessment of the Combination of PSMA-Targeting..:

Ruigrok, Eline ; Verkaik, Nicole ; de Blois, Erik...
International Journal of Molecular Sciences. 23 (2022) 14 - p. 8037 , 2022

Link: https://doi.org/10.3390/..

2

Cationic amphiphilic drugs as potential anticancer therapy ..:

van der Horst, Geertje ; van de Merbel, Arjanneke F. ; Ruigrok, Eline...
Molecular Oncology. 14 (2020) 12 - p. 3121-3134 , 2020

Link: https://doi.org/10.1002/..

3

GRPR versus PSMA: expression profiles during prostate cance..:

Verhoeven, Marjolein ; Ruigrok, Eline A. M. ; van Leenders, Geert J. L. H....
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

In vitro dose effect relationships of actinium-225- and lut..:

Ruigrok, Eline A. M. ; Tamborino, Giulia ; de Blois, Erik...
European Journal of Nuclear Medicine and Molecular Imaging. 49 (2022) 11 - p. 3627-3638 , 2022

Link: https://doi.org/10.1007/..

5

Correction to: In vitro dose effect relationships of actini..:

Ruigrok, Eline A. M. ; Tamborino, Giulia ; de Blois, Erik...
European Journal of Nuclear Medicine and Molecular Imaging. 49 (2022) 11 - p. 3956-3957 , 2022

Link: https://doi.org/10.1007/..

6

Safety of [177Lu]Lu-NeoB treatment: a preclinical study cha..:

Ruigrok, Eline A. M. ; Verhoeven, Marjolein ; Konijnenberg, Mark W....
European Journal of Nuclear Medicine and Molecular Imaging. 49 (2022) 13 - p. 4440-4451 , 2022

Link: https://doi.org/10.1007/..

7

Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radio..:

Tamborino, Giulia ; De Saint-Hubert, Marijke ; Struelens, Lara...
EJNMMI Physics. 7 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

8

Extensive preclinical evaluation of lutetium-177-labeled PS..:

Ruigrok, Eline A. M. ; van Vliet, Nicole ; Dalm, Simone U....
European Journal of Nuclear Medicine and Molecular Imaging. 48 (2020) 5 - p. 1339-1350 , 2020

Link: https://doi.org/10.1007/..

9

The Future of PSMA-Targeted Radionuclide Therapy: An Overvi..:

Ruigrok, Eline A.M. ; van Weerden, Wytske M. ; Nonnekens, Julie.
Pharmaceutics. 11 (2019) 11 - p. 560 , 2019

Link: https://doi.org/10.3390/..

10

Preclinical studies to improve targeted radionuclide therap..:

Ruigrok, Eline
https://pure.eur.nl/en/publications/df7f839a-0bd4-4ff5-b039-0109ae2f3243. , 2023

Link: https://pure.eur.nl/en/p..

11

Cellular dosimetry of Lu-177 Lu-DOTA- Tyr(3) octreotate rad..:

Tamborino, G ; De Saint-Hubert, M ; Struelens, L...
https://pure.eur.nl/en/publications/ff2f0991-8753-4976-96e8-fdba39c6a1b6. , 2020

Link: https://pure.eur.nl/en/p..

12

Cellular dosimetry of Lu-177 Lu-DOTA- Tyr(3) octreotate rad..:

Tamborino, G ; De Saint-Hubert, M ; Struelens, L...
Tamborino , G , De Saint-Hubert , M , Struelens , L , Seoane , DC , Ruigrok , E , Aerts , A , van Cappellen , G , Jong , M , Konijnenberg , M & Nonnekens , J 2020 , ' Cellular dosimetry of Lu-177 Lu-DOTA- Tyr(3) octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicity ' , EJNMMI Physics , vol. 7 , no. 1 , 8 . https://doi.org/10.1186/s40658-020-0276-5. , 2020

Link: https://pure.eur.nl/en/p..

13

Cationic amphiphilic drugs as potential anticancer therapy ..:

van der Horst, Geertje ; van de Merbel, Arjanneke F ; Ruigrok, Eline...
https://boris.unibe.ch/149001/. , 2020

Link: https://boris.unibe.ch/1..

14

The Future of PSMA-Targeted Radionuclide Therapy: An Overvi..:

Ruigrok, Eline ; van Weerden, Wytske ; Nonnekens, Julie.
Ruigrok , E , van Weerden , W , Nonnekens , J & Jong , M 2019 , ' The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research ' , Pharmaceutics , vol. 11 , no. 11 , 560 . https://doi.org/10.3390/pharmaceutics11110560. , 2019

Link: https://pure.eur.nl/en/p..

15

The Future of PSMA-Targeted Radionuclide Therapy: An Overvi..:

Ruigrok, Eline ; van Weerden, Wytske ; Nonnekens, Julie.
https://pure.eur.nl/en/publications/0b3d20ae-f840-4aea-b06f-0897b4456f7f. , 2019

Link: https://pure.eur.nl/en/p..